SCHEMBL2994986

SCHEMBL2994986

CC(C)(C)OC(=O)Cc1ccc(Oc2ccc(NC(=O)c3ccc(Cl)c(Cl)c3)cc2)c(CN)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
HTR2A P28223 2/20 0.44
SLC6A4 P31645 2/20 0.44
STAT3 P40763 1/20 0.44
BCAT2 O15382 1/20 0.43
PTGDR2 Q9Y5Y4 2/20 0.42
MAPT P10636 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 1/20 0.41
PKM P14618 1/20 0.41
KMT2A Q03164 1/20 0.41
CCR2 P41597 3/20 0.41
KCNH2 Q12809 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
BRAF P15056 2/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HDAC1 Q13547 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2992005 0.91 KDM4E (0.51) KDM4EHTR2ASLC6A4BCAT2PTGDR2
SCHEMBL2986645 0.85 PLA2G7 (0.48) KDM4ESTAT3BCAT2PTGDR2MAPT
SCHEMBL2985399 0.84 SMN1; SMN2 (0.46) KDM4EHTR2ASLC6A4STAT3BCAT2
SCHEMBL2988712 0.83 NPC1 (0.46) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL2975710 0.82 LMNA (0.46) KDM4EHTR2ASLC6A4STAT3PTGDR2
SCHEMBL2979962 0.81 LOXL2 (0.46) HTR2ASLC6A4MAPTNPC1RAB9A
SCHEMBL2987871 0.79 PPARA (0.52) PTGDR2MAPTNPC1RAB9AKMT2A
SCHEMBL2991646 0.78 KDM4E (0.60) KDM4EHTR2ASLC6A4BCAT2PTGDR2
SCHEMBL2975708 0.78 MEN1 (0.41) KDM4ESTAT3PTGDR2MAPTNPC1
SCHEMBL14301343 0.77 KDM4E (0.50) KDM4EHTR2ASLC6A4BCAT2PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492437-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2013-07-23 US disclosed
EP-2057115-B9 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-12-26 EP disclosed
EP-2057115-B1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-10-03 EP disclosed
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2012-08-09 US disclosed
US-8183289-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2012-05-22 US disclosed
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2010-07-08 US disclosed
EP-2057115-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES Array Biopharma, Inc. (US) 2009-05-13 EP disclosed
WO-2008024746-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA, INC. (US) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 KDM4E 1078/4885HTR2A 120/4885SLC6A4 1000/4885
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 KDM4E 1078/4885HTR2A 120/4885SLC6A4 1000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.